Moderna, Inc.
MRNA
$35.61
$1.313.82%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -48.46% | 889.13% | |||
| Total Other Revenue | -33.33% | -26.32% | |||
| Total Revenue | -48.12% | 672.61% | |||
| Cost of Revenue | 12.72% | 23.58% | |||
| Gross Profit | -524.17% | 119.27% | |||
| SG&A Expenses | 24.91% | 4.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.49% | 20.45% | |||
| Operating Income | -1,680.00% | 94.86% | |||
| Income Before Tax | -5,738.10% | 101.64% | |||
| Income Tax Expenses | -900.00% | -- | |||
| Earnings from Continuing Operations | -8,715.38% | 101.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8,715.38% | 101.02% | |||
| EBIT | -1,680.00% | 94.86% | |||
| EBITDA | -6,488.89% | 98.64% | |||
| EPS Basic | -8,706.80% | 101.01% | |||
| Normalized Basic EPS | -4,016.84% | 102.38% | |||
| EPS Diluted | -9,830.00% | 100.90% | |||
| Normalized Diluted EPS | -4,158.51% | 102.30% | |||
| Average Basic Shares Outstanding | 0.00% | 0.26% | |||
| Average Diluted Shares Outstanding | -3.51% | 3.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
